Drugging the microbiome and bacterial live biotherapeutic consortium production
Research leading to characterization, quantification, and functional attribution of the microbes throughout the human body has led to many drug-development programs. These programs aim to manipulate a patient’s microbiome through the addition of new strains or functions, the subtraction of deleterio...
Saved in:
Published in | Current opinion in biotechnology Vol. 78; p. 102801 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!